Skip to content

Detection of neonatal sepsis with non-invasive transcutaneous blood gas monitoring

Detection of neonatal sepsis with non-invasive transcutaneous blood gas monitoring

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON22567
Enrollment
32
Registered
2021-10-08
Start date
2020-10-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal late-onset sepsis

Interventions

None listed

Sponsors

Erasmus MC – Sophia Children’s Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A gestational age of 24 weeks up to and including 31 weeks at the time of inclusion. A pulse oximeter as part of regular care. Written informed consent.

Exclusion criteria

Exclusion criteria: A gestational age of 32 weeks or more at the time of inclusion. Skin condition contraindicating transcutaneous measurements. Absence of written informed consent.

Design outcomes

Primary

MeasureTime frame
The relation between transcutaneous blood gas levels and neonatal sepsis.

Secondary

MeasureTime frame
Evaluation of the effect of patient age and time since birth on measurement accuracy. The influence of ventilation and hemodynamic as measured by ventilation parameters, patient monitoring parameters, and registration of applied vasopressors on skin perfusion. Correlation of sensor value deviations and drift from blood gas sample values between measured transcutaneous blood gas levels and heating power to analyze the effects of skin temperature and vascularization on measurement accuracy. Assessment of the measurement quality and accuracy in patients with microcirculatory impairment. Determine the effect of the sensor location on the level and reliability of the measurements. Determine the relation between sepsis indicated by transcutaneous blood gas monitoring and questionnaires recording the clinical considerations for blood culturing by the attending neonatologist.

Contacts

Public ContactMaud Hoofs

Erasmus MC

m.hoofs@erasmusmc.nl0107030390

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)